The New York Times @nytimes
The FDA’s independent panel of vaccine advisers is set to meet Friday to discuss the case for boosters of Pfizer’s coronavirus vaccine. It will also vote on whether the agency should approve additional doses for people 16 and older. https://t.co/Mqk6yfGBAn — PolitiTweet.org